Executive Profile

Ankit Mahadevia M.D. Principal, Atlas Venture L.P.

Age	Total Calculated Compensation	This person is connected to 4 Board Members in 4 different organizations across 7 different industries. See Board Relationships
--	--

Background

Dr. Ankit Mahadevia, MD is a Principal at Atlas Venture L.P. Dr. Mahadevia joined Atlas Venture in 2008 and focuses on the life sciences sector, novel drug discovery platforms, therapeutic products, and other medical technologies that meet a significant unmet clinical need. Previously, Dr. Mahadevia worked on product and business development with the founding team at Arcion Therapeutics Inc. Before that, he held positions in Business Development at Genentech Inc., and ... at Vanda Pharmaceuticals Inc. He is also actively involved in the Shire/Atlas Venture Alliance and the Atlas/Monsanto Seed Fund Alliance. Dr. Mahadevia also served clients in the health services sector at McKinsey and Company. He also has previous experience as a Consultant at Monitor Group, where Dr. Mahadevia supported clients in the biotechnology and medical device industries on strategy, marketing, and business development. He serves on the Boards of Annovation Biopharma, Fibrex Medical Research & Development GesmbH, RaNA Therapeutics, Inc., and Lumavita AG. He serves as a Board Observer at Resolvyx Pharmaceuticals, Nimbus Discovery, and Molecular Biometrics Inc. He also works closely with Arteaus Therapeutics and JenaValve. He previously worked with Sirion Therapeutics. Dr. Mahadevia held roles in the U.S. Government Accountability Office. He also serves on the board of the Johns Hopkins Technology Alliance and as a reviewer for the National Cancer Institute SBIR Bridge Awards. During his medical training he published research in glaucoma therapy and neurovascular interventions. He was appointed by the U.S. Secretary of Health and Human Services to the Advisory Council of the NIH Center for Advancing Translational Sciences. He also serves on board of the Johns Hopkins Alliance for Technology Transfer, through which he promotes translation of biomedical research by biotechnology companies. Dr. Mahadevia completed his M.D. at Johns Hopkins University School of Medicine and his M.B.A. from the Wharton School at the University of Pennsylvania. He graduated summa cum laude with a B.A. in Economics and Biology from Northwestern University.

Corporate Headquarters 25 First Street Cambridge, Massachusetts 02141 United States Phone: 617-588-2600 Fax: 617-588-2601 Board Members Memberships Director Fibrex Medical Research & Development GesmbH Board Observer Molecular Biometrics, Inc. Director Lumavita AG Director RaNA Therapeutics, Inc. Education BA Northwestern University MBA University of Pennsylvania - The Wharton School MD Johns Hopkins School of Medicine Other Affiliations Genentech, Inc. McKinsey & Company, Inc. Northwestern University University of Pennsylvania - The Wharton School Johns Hopkins School of Medicine Fibrex Medical Research & Development GesmbH Vanda Pharmaceuticals, Inc. Arcion Therapeutics, Inc. Molecular Biometrics, Inc. Lumavita AG RaNA Therapeutics, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.